This lack of SMA expression in incisional biopsy samples could direct the diagnosis to tumors of neural origin, such as MPNST or schwannoma, which both express S100 and SOX10 and are typically negative for myogenic markers. The gene discussed is SMN1; the disease is schwannoma.